X

Xeltis

51 employees

Xeltis is a clinical-stage medtech company with the world’s most advanced polymer-based platform of restorative cardiovascular devices.

Basic info

Industry

medical equipment manufacturing

Sectors

Medical Device
Health Care
Therapeutics

Date founded

2006

Funding rounds raised

Total raised

$53M

from 18 investors over 18 rounds

X

Xeltis raised $14M on August 14, 2023

Investors: EQT Life Sciences, Ysios Capital, DaVita Venture Group, VI Partners AG and Grand Patika

X

Xeltis raised $34M on February 21, 2023

Investors: DaVita Venture Group, Grand Pharmaceutical (China) Co., Ltd., EQT Life Sciences and Invest-NL

X

Xeltis raised $15M on August 9, 2022

Investors: Grand Pharmaceutical (China) Co., Ltd.

X

Xeltis raised $17M on November 22, 2021

Investors: European Investment Bank

X

Xeltis raised $53M on November 15, 2017

Investors: VI Partners AG, EQT Life Sciences and Ysios Capital

X

Xeltis raised $3.3M on December 17, 2015

Investors: VI Partners AG and EQT Life Sciences

X

Xeltis raised $34M on December 2, 2014

Investors: VI Partners AG and EQT Life Sciences

FAQ